Eindhoven-based Scinvivo secures €4.7 million to radically improve bladder cancer diagnostics

Published on February 21, 2024

Scinvivo, a medtech startup based in Eindhoven set to revolutionize cancer diagnostics, has closed an investment round of €4.7 million from Santec OIS Corporation, The NLC Health Impact fund, current shareholders, and an “Innovatiekrediet” (Innovation credit) loan of the  Netherlands Enterprise Agency (RvO).  With this investment, Scinvivo will improve the catheter, OCT system, and software…

This content is for members only. Visit the site and log in/register to read.

The post Eindhoven-based Scinvivo secures €4.7 million to radically improve bladder cancer diagnostics appeared first on EU-Startups.